Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA3 | P07451 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA6 | P23280 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14115771 | 0.98 | — | — | |
| SCHEMBL26499223 | 0.98 | — | — | |
| SCHEMBL17293252 | 0.78 | DNM1 (0.40) | TRPV1TRPA1DNM1CA12CA1 | |
| SCHEMBL1117801 | 0.78 | ADH1B (0.54) | CA1TSHRLMNA | |
| SCHEMBL9796748 | 0.77 | NFKB1 (0.39) | TRPV1DNM1CA12CA1CA2 | |
| SCHEMBL19577886 | 0.76 | DNM1 (0.38) | TRPV1TRPA1DNM1CA12CA1 | |
| SCHEMBL4698371 | 0.75 | — | — | |
| SCHEMBL20207821 | 0.75 | — | — | |
| SCHEMBL9337939 | 0.74 | TRPV1 (0.40) | TRPV1TRPA1DNM1GNAI3GNAO1 | |
| SCHEMBL16260137 | 0.73 | NFKB1 (0.35) | TRPV1TRPA1DNM1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230277725-A1 | COACERVATE HYALURONAN HYDROGELS FOR DERMAL FILLER APPLICATIONS | ALLERGAN INC (US) | 2023-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277725-A1 | COACERVATE HYALURONAN HYDROGELS FOR DERMAL FILLER APPLICATIONS | CD44, CHIT1, CHIA | TRPV1 1224/4885TRPA1 1671/4885DNM1 3886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.